Cas no 679428-14-9 (Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)-)
Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- Chemical and Physical Properties
Names and Identifiers
-
- Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)-
- 2,6-dimethoxy-4-phenylmethoxybenzaldehyde
- AKOS023413610
- 4-benzyloxy-2,6-dimethoxybenzaldehyde
- DTXSID90404816
- 679428-14-9
- SCHEMBL1745424
- YHMXRPWCVSRREV-UHFFFAOYSA-N
- MS-11547
- 4-(benzyloxy)-2,6-dimethoxybenzaldehyde
-
- MDL: MFCD12025135
- Inchi: 1S/C16H16O4/c1-18-15-8-13(9-16(19-2)14(15)10-17)20-11-12-6-4-3-5-7-12/h3-10H,11H2,1-2H3
- InChI Key: YHMXRPWCVSRREV-UHFFFAOYSA-N
- SMILES: O(CC1C=CC=CC=1)C1C=C(C(C=O)=C(C=1)OC)OC
Computed Properties
- Exact Mass: 272.10488
- Monoisotopic Mass: 272.10485899g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 20
- Rotatable Bond Count: 6
- Complexity: 274
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.8
- Topological Polar Surface Area: 44.8?2
Experimental Properties
- PSA: 44.76
Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| A2B Chem LLC | AC82381-1mg |
4-(Benzyloxy)-2,6-dimethoxybenzaldehyde |
679428-14-9 | >97% | 1mg |
$201.00 | 2024-04-19 | |
| A2B Chem LLC | AC82381-5g |
4-(Benzyloxy)-2,6-dimethoxybenzaldehyde |
679428-14-9 | >97% | 5g |
$208.00 | 2024-04-19 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1536831-5g |
4-(Benzyloxy)-2,6-dimethoxybenzaldehyde |
679428-14-9 | 98% | 5g |
¥358.00 | 2024-05-04 |
Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- Related Literature
-
1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
Additional information on Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)-
Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- and Its Significance in Modern Chemical Research
Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) is a highly specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its intricate molecular structure, exhibits a unique combination of functional groups that make it a versatile intermediate in the synthesis of various bioactive molecules. The presence of both methoxy and phenylmethoxy substituents on the benzaldehyde core imparts distinct chemical properties that are exploited in multiple applications, ranging from drug development to material science.
The molecular architecture of Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) is a testament to the ingenuity of synthetic organic chemistry. The compound features a benzaldehyde backbone substituted at the 2- and 6-positions with methoxy groups, and at the 4-position with a phenylmethoxy group. This specific arrangement not only enhances its reactivity but also opens up numerous possibilities for further functionalization. The methoxy groups contribute to the compound's solubility in polar solvents, while the phenylmethoxy group introduces steric hindrance and electronic effects that can be leveraged in designing molecules with specific biological activities.
In recent years, there has been a surge in research focusing on the development of novel therapeutic agents derived from natural product-inspired scaffolds. Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) has emerged as a key intermediate in this context. Its structural features are reminiscent of many bioactive compounds found in plants and fungi, which have been traditionally used in folk medicine. The compound's ability to serve as a precursor for more complex molecules has made it invaluable in the quest for new drugs targeting various diseases.
One of the most compelling aspects of Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) is its role in the synthesis of heterocyclic compounds. Heterocycles are essential components of many pharmaceuticals due to their ability to mimic natural products and interact with biological targets in specific ways. Researchers have utilized this compound to construct complex scaffolds that exhibit potent activity against pathogens and chronic diseases. For instance, derivatives of this molecule have shown promise in inhibiting enzymes involved in cancer progression and inflammatory responses.
The pharmaceutical industry has been particularly interested in exploring the potential of Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) as a building block for drug candidates. Its structural motif is found in several approved drugs that demonstrate efficacy across a wide range of therapeutic areas. The compound's versatility allows chemists to modify its structure systematically, enabling the optimization of pharmacokinetic properties such as solubility, bioavailability, and metabolic stability. This flexibility is crucial for developing drugs that can be effectively administered and tolerated by patients.
Advances in computational chemistry have further enhanced the utility of Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) in drug discovery. Molecular modeling techniques allow researchers to predict how this compound will interact with biological targets at the atomic level. By simulating these interactions computationally, scientists can identify potential lead compounds before investing significant resources in experimental synthesis and testing. This approach has accelerated the drug development pipeline significantly over recent years.
The synthesis of Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) itself is an intricate process that requires precise control over reaction conditions and reagent selection. Modern synthetic methodologies have enabled more efficient and scalable production methods compared to traditional approaches. Catalytic processes and green chemistry principles have been employed to minimize waste and energy consumption while maintaining high yields. These advancements not only make the compound more accessible but also align with global efforts to promote sustainable chemical practices.
In conclusion, Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)- (CAS No. 679428-14-9) represents a significant advancement in chemical biology and pharmaceutical research. Its unique structural features make it a valuable intermediate for synthesizing bioactive molecules with potential therapeutic applications. As research continues to uncover new uses for this compound, it is likely to play an even greater role in the development of innovative treatments for human diseases.
679428-14-9 (Benzaldehyde, 2,6-dimethoxy-4-(phenylmethoxy)-) Related Products
- 5896-17-3(2-(Benzyloxy)benzaldehyde)
- 14389-86-7(2-Benzyloxybenzoic acid)
- 58026-14-5(4-Benzyloxy-2-methoxybenzaldehyde)
- 134-11-2(2-Ethoxybenzoic acid)
- 165662-68-0(3-Benzyloxy-4-methylbenzoic Acid)
- 52085-14-0(4-Benzyloxy-2-hydroxybenzaldehyde)
- 22924-16-9(2,4-Diethoxybenzaldehyde)
- 144896-51-5(4-(Benzyloxy)-3,5-dimethylbenzaldehyde)
- 13246-46-3(2,4-Bis(benzyloxy)benzaldehyde)
- 161192-21-8(2-(Benzyloxy)-5-hydroxybenzaldehyde)